We believe collaboration is the best way to accelerate the discovery and development of new cures for pediatric cancer.
As a collaborative, we’re focused on expanding trials and patient access, sharing expertise and data, and accelerating the development of these promising cures.
Unprecedented CAR T experience and technologies, including process expertise to accelerate translation from “bench to bedside.”
Members leverage individual and collective expertise around CAR T-cell therapies, clinical trials management, grants, regulatory affairs, and manufacturing.
Members gain access to GMP facility to produce treatments for their patients at a reduced level of capital investment.
Management of external communications with constituent communities, government agencies, media, and other stakeholders.
Expanded access to diverse participant pool, streamlined enrollment process, multi-site trial strategy, and regulatory agency expertise.
For kids to grow up to realize their full potential. CureWorks is pursuing breakthrough cancer immunotherapies designed to treat children without the side effects that can have long-term, debilitating impact on young brains and bodies.FOR PARENTS